TGFB1 and neoplasm: TGF‐β is a very potent immunosuppressant; long‐term systematic blockage of TGF‐β may result in autoimmunity in patients; therefore, it is critical to find the delicate balance between tumor immunity and autoimmunity maintained by Tregs cells in treating tumors.